Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 338,549 | 68 | 3,149 | N/A | N/A |
| TOTAL | $342,137 | $103 | $3,242 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 75 | 26 | 26 | N/A | N/A |
| Other Non-Current Assets | 510 | 3 | 3 | 0 | 0 |
| TOTAL | $585 | $29 | $29 | $N/A | $N/A |
| Total Assets | $342,722 | $132 | $3,271 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 719 | 935 | 116 | 0 | 0 |
| Other current liabilities | 3,866 | 443 | 85 | N/A | N/A |
| TOTAL | $4,585 | $1,378 | $201 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,585 | $1,378 | $201 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 3 | N/A | 0 | N/A | N/A |
| Retained earnings | -33,094 | -10,762 | -6,446 | N/A | N/A |
| Other shareholders' equity | 0 | 9,348 | 9,348 | 0 | 0 |
| TOTAL | $338,137 | $-1,246 | $3,070 | $N/A | $N/A |
| Total Liabilities And Equity | $342,722 | $132 | $3,271 | $0 | $0 |